NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10(NVZMY.US) will release financial report on November 7th.
$NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10(NVZMY.US)$ will release its financial report on November 7th, investors are welcome to pay attention. How was the previous performance? $NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10(NVZMY.US)$ Revenue for 2023 Q4 was 0.625086 billion euros, with a net income of 9,455.3707.
Novozymes A/S Goes Ex Dividend Monday
NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10 To Go Ex-Dividend On September 9th, 2024 With 0.29841 USD Dividend Per Share
NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10 To Go Ex-Dividend On May 1st, 2024 With 0.28851 USD Dividend Per Share
Is CalMaine Foods (CALM) Stock Outpacing Its Basic Materials Peers This Year?
MATV or NVZMY: Which Is the Better Value Stock Right Now?
Are Basic Materials Stocks Lagging Novozymes (NVZMY) This Year?
MATV Vs. NVZMY: Which Stock Is the Better Value Option?
DJ Symbol for Novozymes A/S (NZYM-B.KO) Now NSIS-B.KO
Resolutions From the Extraordinary Shareholders' Meeting 2024
Is Novozymes (NVZMY) Stock Outpacing Its Basic Materials Peers This Year?
MATV Vs. NVZMY: Which Stock Should Value Investors Buy Now?
Novo Nordisk's Parent Eyes $7B Annual Investments by 2030: FT
Recap: Novozymes Q4 Earnings
Novozymes's Solutions Boosted by AI, CEO Says -- Market Talk
EU: Decision Is Conditional Upon Full Compliance With Commitments
EU: Parties Offered to Divest Some Operations to Address Competition Concerns
EU Approves Novozymes and Chr. Hansen Merger, Subject to Conditions
Wall Street's 20 Most Overbought Stocks
Novozymes A/S Goes Ex-dividend Tomorrow
No Data